COL Portal -

Description	Reuse
No se encontraron registros.

Gene	Gene regions	Relations to island	Options
No se encontraron registros.

Results

Clinical case
CP-1 Nationality: Spa Status: tumoral Age: 83 Grouped Age: 78+ Type: Serrated Adenocarcinoma Localization: distal General loc.: left TNM: T3N1M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: <10 (0-5) Mucina: abs Necrosis: confl MSI: MSI Mutations: Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(no met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met) View tissue
CP-2 Nationality: Spa Status: tumoral Age: 83 Grouped Age: 78+ Type: CRIBIF-COMEDO Localization: proximal General loc.: cecum TNM: T4N2M1 Grading: LG Invasion: false Perforation: false Growth: inf Budding: Low TB grading: <10 (0-5) Mucina: < 50% Necrosis: confl MSI: MSS Mutations: Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(no met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met) View tissue
CP-3 Nationality: Spa Status: tumoral Age: 71 Grouped Age: 66 - 73 Type: Conventional Carcinoma Localization: proximal General loc.: cecum TNM: T3N1MX Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: abs Mucina: < 50% Necrosis: intrag MSI: MSS Mutations: KRAS PI3K Exon: 9 Methilation: CACNA1G(no met) CDKN2A(parcial met) CRABP1(met) IGF2(met) MLH1(no met) NEUROG1(met) RUNX3(met) SOCS1(no met) View tissue
CP-4 Nationality: Spa Status: normal Age: 65 Grouped Age: <= 65 Type: Serrated Adenocarcinoma Localization: distal General loc.: sigmoid TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-5 Nationality: Spa Status: tumoral Age: 65 Grouped Age: <= 65 Type: Serrated Adenocarcinoma Localization: proximal General loc.: sigmoid TNM: T4N1M1 Grading: HG Invasion: false Perforation: false Growth: exp Budding: High TB grading: >20 (>12) Mucina: < 50% Necrosis: diff MSI: MSS Mutations: BRAF PI3K Exon: 9 Methilation: CACNA1G(met) CDKN2A(parcial met) CRABP1(met) IGF2(met) MLH1(no met) NEUROG1(met) RUNX3(met) SOCS1(no met) View tissue
CP-6 Nationality: Spa Status: tumoral Age: 72 Grouped Age: 66 - 73 Type: Conventional Carcinoma Localization: proximal General loc.: cecum TNM: T2N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: <10 (0-5) Mucina: abs Necrosis: intrag MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(no met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met)
CP-7 Nationality: Spa Status: tumoral Age: 75 Grouped Age: 74 - 77 Type: Serrated Adenocarcinoma Localization: proximal General loc.: ascending TNM: T2N1M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: <10 (0-5) Mucina: > 75% Necrosis: abs MSI: MSS Mutations: KRAS Methilation: View tissue
CP-8 Nationality: Spa Status: normal Age: 57 Grouped Age: <= 65 Type: Serrated Adenocarcinoma Localization: distal General loc.: left TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-9 Nationality: Spa Status: tumoral Age: 57 Grouped Age: <= 65 Type: Serrated Adenocarcinoma Localization: distal General loc.: left TNM: T3N2M1 Grading: LG Invasion: false Perforation: false Growth: exp Budding: High TB grading: >20 (>12) Mucina: > 75% Necrosis: abs MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(parcial met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met) View tissue
CP-10 Nationality: Spa Status: normal Age: 75 Grouped Age: 74 - 77 Type: Conventional Carcinoma Localization: proximal General loc.: cecum TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-11 Nationality: Spa Status: tumoral Age: 75 Grouped Age: 74 - 77 Type: Conventional Carcinoma Localization: proximal General loc.: cecum TNM: T4N2M0 Grading: LG Invasion: false Perforation: false Growth: inf Budding: Low TB grading: <10 (0-5) Mucina: abs Necrosis: confl MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(parcial met) CRABP1(met) IGF2(met) MLH1(no met) NEUROG1(met) RUNX3(met) SOCS1(no met) View tissue
CP-12 Nationality: Spa Status: tumoral Age: 78 Grouped Age: 78+ Type: Microsatellite Instable Localization: proximal General loc.: cecum TNM: T4N1M0 Grading: HG Invasion: false Perforation: false Growth: exp Budding: no TB grading: abs Mucina: abs Necrosis: diff MSI: MSI Mutations: PI3K Exon: 9 Methilation: CACNA1G(parcial met) CDKN2A(met) CRABP1(met) IGF2(met) MLH1(met) NEUROG1(met) RUNX3(met) SOCS1(no met)
CP-13 Nationality: Spa Status: normal Age: 56 Grouped Age: <= 65 Type: Serrated Adenocarcinoma Localization: proximal General loc.: cecum TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-14 Nationality: Spa Status: tumoral Age: 56 Grouped Age: <= 65 Type: Serrated Adenocarcinoma Localization: proximal General loc.: cecum TNM: T2N1M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: <10 (0-5) Mucina: abs Necrosis: abs MSI: MSS Mutations: Methilation: CACNA1G(no met) CDKN2A(parcial met) CRABP1(met) IGF2(met) MLH1(no met) NEUROG1(met) RUNX3(no met) SOCS1(no met) View tissue
CP-15 Nationality: Spa Status: normal Age: 64 Grouped Age: <= 65 Type: Conventional Carcinoma Localization: rectum General loc.: sigmoid TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-16 Nationality: Spa Status: tumoral Age: 64 Grouped Age: <= 65 Type: Conventional Carcinoma Localization: distal General loc.: sigmoid TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: <10 (0-5) Mucina: abs Necrosis: intrag MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(no met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met)
CP-17 Nationality: Spa Status: normal Age: 83 Grouped Age: 78+ Type: Serrated Adenocarcinoma Localization: rectum General loc.: rectum TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-18 Nationality: Spa Status: tumoral Age: 83 Grouped Age: 78+ Type: Serrated Adenocarcinoma Localization: rectum General loc.: rectum TNM: T2N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: abs Mucina: > 75% Necrosis: abs MSI: MSS Mutations: Methilation:
CP-19 Nationality: Spa Status: normal Age: 48 Grouped Age: <= 65 Type: Microsatellite Instable Localization: proximal General loc.: ascending TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-20 Nationality: Spa Status: tumoral Age: 48 Grouped Age: <= 65 Type: Microsatellite Instable Localization: proximal General loc.: ascending TNM: T3N0M0 Grading: HG Invasion: false Perforation: false Growth: exp Budding: no TB grading: abs Mucina: abs Necrosis: abs MSI: MSI Mutations: Methilation:
CP-21 Nationality: Spa Status: tumoral Age: 76 Grouped Age: 74 - 77 Type: Conventional Carcinoma Localization: distal General loc.: left TNM: T4N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: <10 (0-5) Mucina: abs Necrosis: intrag MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(met) MLH1(no met) NEUROG1(met) RUNX3(no met) SOCS1(no met) View tissue
CP-22 Nationality: Spa Status: normal Age: 76 Grouped Age: 74 - 77 Type: Serrated Adenocarcinoma Localization: proximal General loc.: cecum TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-23 Nationality: Spa Status: tumoral Age: 76 Grouped Age: 74 - 77 Type: Serrated Adenocarcinoma Localization: proximal General loc.: cecum TNM: T2N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: <10 (0-5) Mucina: < 50% Necrosis: abs MSI: MSI Mutations: Methilation: CACNA1G(parcial met) CDKN2A(parcial met) CRABP1(met) IGF2(met) MLH1(met) NEUROG1(met) RUNX3(met) SOCS1(no met)
CP-24 Nationality: Spa Status: tumoral Age: 78 Grouped Age: 78+ Type: Serrated Adenocarcinoma Localization: proximal General loc.: ascending TNM: T3N1M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: abs Mucina: > 75% Necrosis: abs MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(parcial met) CRABP1(no met) IGF2(met) MLH1(no met) NEUROG1(met) RUNX3(no met) SOCS1(no met) View tissue
CP-25 Nationality: Spa Status: normal Age: 64 Grouped Age: <= 65 Type: Microsatellite Instable Localization: proximal General loc.: cecum TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-26 Nationality: Spa Status: tumoral Age: 64 Grouped Age: <= 65 Type: Microsatellite Instable Localization: proximal General loc.: cecum TNM: T3N2M0 Grading: HG Invasion: false Perforation: false Growth: exp Budding: no TB grading: abs Mucina: < 50% Necrosis: abs MSI: MSI Mutations: BRAF Methilation: CACNA1G(met) CDKN2A(met) CRABP1(met) IGF2(met) MLH1(met) NEUROG1(met) RUNX3(met) SOCS1(no met) View tissue
CP-27 Nationality: Spa Status: tumoral Age: 66 Grouped Age: 66 - 73 Type: Serrated Adenocarcinoma Localization: proximal General loc.: cecum TNM: T4N2M1 Grading: LG Invasion: false Perforation: false Growth: inf Budding: High TB grading: 10-19 (>12) Mucina: > 75% Necrosis: intrag MSI: MSS Mutations: PI3K Exon: 20 Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(parcial met) IGF2(met) MLH1(no met) NEUROG1(parcial met) RUNX3(no met) SOCS1(no met)
CP-28 Nationality: Spa Status: tumoral Age: 60 Grouped Age: <= 65 Type: Conventional Carcinoma Localization: proximal General loc.: ascending TNM: T4N2M0 Grading: LG Invasion: false Perforation: false Growth: inf Budding: Low TB grading: <10 (0-5) Mucina: abs Necrosis: abs MSI: MSS Mutations: Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(parcial met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met) View tissue
CP-29 Nationality: Spa Status: tumoral Age: 54 Grouped Age: <= 65 Type: Conventional Carcinoma Localization: proximal General loc.: transverse TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: abs Mucina: > 75% Necrosis: abs MSI: MSS Mutations: KRAS PI3K Exon: 20 Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(met) IGF2(parcial met) MLH1(no met) NEUROG1(met) RUNX3(no met) SOCS1(no met) View tissue
CP-30 Nationality: Spa Status: tumoral Age: 39 Grouped Age: <= 65 Type: Microsatellite Instable Localization: proximal General loc.: cecum TNM: T3N0M0 Grading: HG Invasion: false Perforation: false Growth: exp Budding: no TB grading: abs Mucina: abs Necrosis: diff MSI: MSI Mutations: BRAF Methilation: CACNA1G(met) CDKN2A(met) CRABP1(met) IGF2(met) MLH1(met) NEUROG1(met) RUNX3(met) SOCS1(no met) View tissue
CP-31 Nationality: Spa Status: normal Age: 76 Grouped Age: 74 - 77 Type: Serrated Adenocarcinoma Localization: proximal General loc.: cecum TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-32 Nationality: Spa Status: tumoral Age: 76 Grouped Age: 74 - 77 Type: Serrated Adenocarcinoma Localization: proximal General loc.: cecum TNM: T4N2M1 Grading: HG Invasion: false Perforation: false Growth: inf Budding: High TB grading: >20 (>12) Mucina: < 50% Necrosis: intrag MSI: MSS Mutations: BRAF Methilation: CACNA1G(no met) CDKN2A(parcial met) CRABP1(parcial met) IGF2(met) MLH1(parcial met) NEUROG1(met) RUNX3(met) SOCS1(no met) View tissue
CP-33 Nationality: Spa Status: tumoral Age: 65 Grouped Age: <= 65 Type: Conventional Carcinoma Localization: proximal General loc.: cecum TNM: T4N2M0 Grading: LG Invasion: Perforation: Growth: Budding: TB grading: Mucina: abs Necrosis: MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(no met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met) View tissue
CP-34 Nationality: Spa Status: normal Age: 68 Grouped Age: 66 - 73 Type: Serrated Adenocarcinoma Localization: proximal General loc.: cecum TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-35 Nationality: Spa Status: tumoral Age: 68 Grouped Age: 66 - 73 Type: Serrated Adenocarcinoma Localization: proximal General loc.: cecum TNM: T4N1M0 Grading: LG Invasion: false Perforation: false Growth: inf Budding: High TB grading: >20 (>12) Mucina: < 50% Necrosis: abs MSI: MSS Mutations: BRAF KRAS Methilation: CACNA1G(parcial met) CDKN2A(parcial met) CRABP1(met) IGF2(met) MLH1(no met) NEUROG1(met) RUNX3(met) SOCS1(no met)
CP-36 Nationality: Spa Status: tumoral Age: 74 Grouped Age: 74 - 77 Type: Microsatellite Instable Localization: proximal General loc.: cecum TNM: T4N1M1 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: abs Mucina: abs Necrosis: abs MSI: MSS Mutations: Methilation: CACNA1G(met) CDKN2A(parcial met) CRABP1(met) IGF2(met) MLH1(met) NEUROG1(met) RUNX3(met) SOCS1(no met) View tissue
CP-37 Nationality: Spa Status: tumoral Age: 85 Grouped Age: 78+ Type: Microsatellite Instable Localization: proximal General loc.: cecum TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: abs Mucina: < 50% Necrosis: diff MSI: MSI Mutations: BRAF Methilation: CACNA1G(met) CDKN2A(met) CRABP1(met) IGF2(met) MLH1(met) NEUROG1(met) RUNX3(met) SOCS1(no met) View tissue
CP-38 Nationality: Spa Status: tumoral Age: 67 Grouped Age: 66 - 73 Type: Serrated Adenocarcinoma Localization: proximal General loc.: cecum TNM: T3N2M0 Grading: LG Invasion: false Perforation: false Growth: inf Budding: High TB grading: 10-19 (>12) Mucina: abs Necrosis: intrag MSI: MSS Mutations: Methilation: CACNA1G(no met) CDKN2A(parcial met) CRABP1(no met) IGF2(no met) MLH1(no met) NEUROG1(met) RUNX3(no met) SOCS1(no met) View tissue
CP-39 Nationality: Spa Status: tumoral Age: 73 Grouped Age: 66 - 73 Type: Conventional Carcinoma Localization: proximal General loc.: ascending TNM: T2N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: <10 (0-5) Mucina: abs Necrosis: intrag MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(parcial met) CRABP1(no met) IGF2(parcial met) MLH1(no met) NEUROG1(met) RUNX3(met) SOCS1(no met)
CP-40 Nationality: Spa Status: tumoral Age: 71 Grouped Age: 66 - 73 Type: Serrated Adenocarcinoma Localization: proximal General loc.: ascending TNM: T2N0M1 Grading: HG Invasion: false Perforation: false Growth: exp Budding: High TB grading: 10-19 (>12) Mucina: 50-75% Necrosis: intrag MSI: MSS Mutations: Methilation: CACNA1G(parcial met) CDKN2A(parcial met) CRABP1(parcial met) IGF2(met) MLH1(no met) NEUROG1(met) RUNX3(no met) SOCS1(no met) View tissue
CP-41 Nationality: Spa Status: tumoral Age: 86 Grouped Age: 78+ Type: Microsatellite Instable Localization: proximal General loc.: cecum TNM: T3N2M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: abs Mucina: > 75% Necrosis: abs MSI: MSI Mutations: KRAS Methilation: CACNA1G(met) CDKN2A(parcial met) CRABP1(parcial met) IGF2(met) MLH1(met) NEUROG1(met) RUNX3(met) SOCS1(no met)
CP-42 Nationality: Spa Status: normal Age: 77 Grouped Age: 74 - 77 Type: Serrated Adenocarcinoma Localization: proximal General loc.: cecum TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-43 Nationality: Spa Status: tumoral Age: 77 Grouped Age: 74 - 77 Type: Serrated Adenocarcinoma Localization: proximal General loc.: cecum TNM: T4N2MX Grading: HG Invasion: false Perforation: false Growth: inf Budding: High TB grading: >20 (>12) Mucina: > 75% Necrosis: intrag MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(parcial met) CRABP1(no met) IGF2(met) MLH1(no met) NEUROG1(parcial met) RUNX3(no met) SOCS1(no met) View tissue
CP-44 Nationality: Spa Status: tumoral Age: 75 Grouped Age: 74 - 77 Type: Conventional Carcinoma Localization: distal General loc.: sigmoid TNM: T2N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: abs Mucina: abs Necrosis: intrag MSI: MSS Mutations: Methilation: CACNA1G(parcial met) CDKN2A(parcial met) CRABP1(met) IGF2(met) MLH1(no met) NEUROG1(met) RUNX3(no met) SOCS1(no met)
CP-45 Nationality: Spa Status: tumoral Age: 69 Grouped Age: 66 - 73 Type: Conventional Carcinoma Localization: proximal General loc.: cecum TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: inf Budding: High TB grading: >20 (>12) Mucina: abs Necrosis: confl MSI: MSS Mutations: Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(met) MLH1(no met) NEUROG1(met) RUNX3(parcial met) SOCS1(no met)
CP-46 Nationality: Spa Status: tumoral Age: 64 Grouped Age: <= 65 Type: Serrated Adenocarcinoma Localization: distal General loc.: splenic TNM: T2N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: TB grading: 10-19 (>12) Mucina: < 50% Necrosis: abs MSI: MSS Mutations: KRAS PI3K Exon: 9 Methilation: CACNA1G(no met) CDKN2A(parcial met) CRABP1(parcial met) IGF2(met) MLH1(no met) NEUROG1(met) RUNX3(parcial met) SOCS1(no met)
CP-47 Nationality: Spa Status: tumoral Age: 74 Grouped Age: 74 - 77 Type: Conventional Carcinoma Localization: proximal General loc.: cecum TNM: T3N2M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: <10 (0-5) Mucina: < 50% Necrosis: intrag MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(parcial met) IGF2(met) MLH1(no met) NEUROG1(met) RUNX3(parcial met) SOCS1(no met)
CP-48 Nationality: Spa Status: tumoral Age: 63 Grouped Age: <= 65 Type: Serrated Adenocarcinoma Localization: proximal General loc.: cecum TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: abs Mucina: > 75% Necrosis: abs MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(met) MLH1(no met) NEUROG1(met) RUNX3(no met) SOCS1(no met) View tissue
CP-49 Nationality: Spa Status: normal Age: 69 Grouped Age: 66 - 73 Type: Microsatellite Instable Localization: proximal General loc.: ascending TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-50 Nationality: Spa Status: tumoral Age: 69 Grouped Age: 66 - 73 Type: Microsatellite Instable Localization: proximal General loc.: ascending TNM: T4N2M1 Grading: LG Invasion: false Perforation: false Growth: inf Budding: High TB grading: 10-19 (>12) Mucina: 50-75% Necrosis: diff MSI: MSI Mutations: KRAS Methilation: CACNA1G(met) CDKN2A(parcial met) CRABP1(met) IGF2(met) MLH1(met) NEUROG1(met) RUNX3(met) SOCS1(no met)
CP-51 Nationality: Spa Status: tumoral Age: 65 Grouped Age: <= 65 Type: Serrated Adenocarcinoma Localization: proximal General loc.: transverse TNM: T3N0M0 Grading: HG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: abs Mucina: > 75% Necrosis: abs MSI: MSI Mutations: BRAF Methilation: CACNA1G(met) CDKN2A(parcial met) CRABP1(met) IGF2(met) MLH1(met) NEUROG1(met) RUNX3(met) SOCS1(no met)
CP-52 Nationality: Spa Status: tumoral Age: 80 Grouped Age: 78+ Type: Serrated Adenocarcinoma Localization: proximal General loc.: cecum TNM: T4N2M0 Grading: LG Invasion: false Perforation: false Growth: inf Budding: Low TB grading: <10 (0-5) Mucina: < 50% Necrosis: abs MSI: MSS Mutations: KRAS Methilation: CACNA1G(parcial met) CDKN2A(parcial met) CRABP1(parcial met) IGF2(met) MLH1(no met) NEUROG1(met) RUNX3(met) SOCS1(no met) View tissue
CP-53 Nationality: Spa Status: tumoral Age: 91 Grouped Age: 78+ Type: Conventional Carcinoma Localization: proximal General loc.: transverse TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: abs Mucina: abs Necrosis: intrag MSI: MSS Mutations: Methilation: CACNA1G(no met) CDKN2A(parcial met) CRABP1(parcial met) IGF2(parcial met) MLH1(no met) NEUROG1(parcial met) RUNX3(no met) SOCS1(no met) View tissue
CP-54 Nationality: Spa Status: normal Age: 76 Grouped Age: 74 - 77 Type: Microsatellite Instable Localization: proximal General loc.: ascending TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-55 Nationality: Spa Status: tumoral Age: 76 Grouped Age: 74 - 77 Type: Microsatellite Instable Localization: proximal General loc.: ascending TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: no TB grading: abs Mucina: < 50% Necrosis: abs MSI: MSS Mutations: Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(no met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met) View tissue
CP-56 Nationality: Spa Status: normal Age: 69 Grouped Age: 66 - 73 Type: Microsatellite Instable Localization: proximal General loc.: cecum TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-57 Nationality: Spa Status: tumoral Age: 69 Grouped Age: 66 - 73 Type: Microsatellite Instable Localization: proximal General loc.: cecum TNM: T4N0M1 Grading: LG Invasion: false Perforation: false Growth: exp Budding: High TB grading: >20 (>12) Mucina: abs Necrosis: abs MSI: MSI Mutations: BRAF Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(no met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met) View tissue
CP-58 Nationality: Spa Status: normal Age: 72 Grouped Age: 66 - 73 Type: Conventional Carcinoma Localization: distal General loc.: sigmoid TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-59 Nationality: Spa Status: tumoral Age: 72 Grouped Age: 66 - 73 Type: Conventional Carcinoma Localization: distal General loc.: sigmoid TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: abs Mucina: abs Necrosis: confl MSI: MSS Mutations: Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(parcial met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met) View tissue
CP-60 Nationality: Spa Status: normal Age: 65 Grouped Age: <= 65 Type: Conventional Carcinoma Localization: distal General loc.: sigmoid TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-61 Nationality: Spa Status: tumoral Age: 65 Grouped Age: <= 65 Type: Conventional Carcinoma Localization: distal General loc.: sigmoid TNM: T3N0M0 Grading: Invasion: false Perforation: false Growth: exp Budding: Low TB grading: abs Mucina: abs Necrosis: intrag MSI: MSS Mutations: KRAS PI3K Exon: 20 Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(parcial met) IGF2(met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met)
CP-62 Nationality: Spa Status: tumoral Age: 79 Grouped Age: 78+ Type: Serrated Adenocarcinoma Localization: proximal General loc.: cecum TNM: T3N1M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: abs Mucina: < 50% Necrosis: intrag MSI: MSI Mutations: BRAF Methilation: CACNA1G(met) CDKN2A(met) CRABP1(met) IGF2(met) MLH1(met) NEUROG1(met) RUNX3(met) SOCS1(no met)
CP-63 Nationality: Spa Status: tumoral Age: 78 Grouped Age: 78+ Type: Serrated Adenocarcinoma Localization: distal General loc.: left TNM: T2N1M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: High TB grading: 10-19 (>12) Mucina: > 75% Necrosis: abs MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(parcial met) MLH1(no met) NEUROG1(parcial met) RUNX3(no met) SOCS1(no met)
CP-64 Nationality: Spa Status: normal Age: 66 Grouped Age: 66 - 73 Type: Conventional Carcinoma Localization: distal General loc.: sigmoid TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: abs Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-65 Nationality: Spa Status: tumoral Age: 66 Grouped Age: 66 - 73 Type: Conventional Carcinoma Localization: distal General loc.: sigmoid TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: High TB grading: <10 (0-5) Mucina: abs Necrosis: confl MSI: MSS Mutations: Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(met) MLH1(no met) NEUROG1(parcial met) RUNX3(no met) SOCS1(no met)
CP-66 Nationality: Spa Status: normal Age: 78 Grouped Age: 78+ Type: Conventional Carcinoma Localization: proximal General loc.: ascending TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-67 Nationality: Spa Status: tumoral Age: 78 Grouped Age: 78+ Type: Conventional Carcinoma Localization: proximal General loc.: ascending TNM: T3N1M0 Grading: LG Invasion: false Perforation: false Growth: inf Budding: High TB grading: 10-19 (>12) Mucina: abs Necrosis: intrag MSI: MSS Mutations: Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(parcial met) IGF2(met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met) View tissue
CP-68 Nationality: Spa Status: tumoral Age: 70 Grouped Age: 66 - 73 Type: Conventional Carcinoma Localization: proximal General loc.: cecum TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: abs Mucina: abs Necrosis: confl MSI: MSS Mutations: KRAS PI3K Exon: 9 Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(met) MLH1(no met) NEUROG1(met) RUNX3(no met) SOCS1(no met) View tissue
CP-69 Nationality: Spa Status: normal Age: 76 Grouped Age: 74 - 77 Type: Microsatellite Instable Localization: proximal General loc.: cecum TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-70 Nationality: Spa Status: tumoral Age: 76 Grouped Age: 74 - 77 Type: Microsatellite Instable Localization: proximal General loc.: cecum TNM: T3N2M1 Grading: LG Invasion: false Perforation: false Growth: exp Budding: High TB grading: >20 (>12) Mucina: 50-75% Necrosis: confl MSI: MSS Mutations: Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(no met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met) View tissue
CP-71 Nationality: Spa Status: normal Age: 88 Grouped Age: 78+ Type: Conventional Carcinoma Localization: rectum General loc.: rectum-sigmoid TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-72 Nationality: Spa Status: tumoral Age: 88 Grouped Age: 78+ Type: Conventional Carcinoma Localization: rectum General loc.: rectum-sigmoid TNM: T3N2M1 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: <10 (0-5) Mucina: < 50% Necrosis: confl MSI: MSS Mutations: Methilation: CACNA1G(no met) CDKN2A(parcial met) CRABP1(no met) IGF2(parcial met) MLH1(no met) NEUROG1(parcial met) RUNX3(no met) SOCS1(no met) View tissue
CP-73 Nationality: Spa Status: tumoral Age: 75 Grouped Age: 74 - 77 Type: Conventional Carcinoma Localization: distal General loc.: sigmoid TNM: T4N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: abs Mucina: abs Necrosis: confl MSI: MSS Mutations: Methilation: CACNA1G(no met) CDKN2A(parcial met) CRABP1(no met) IGF2(parcial met) MLH1(no met) NEUROG1(parcial met) RUNX3(no met) SOCS1(no met)
CP-74 Nationality: Spa Status: tumoral Age: 54 Grouped Age: <= 65 Type: Serrated Adenocarcinoma Localization: proximal General loc.: TNM: T3N2M1 Grading: HG Invasion: false Perforation: false Growth: inf Budding: High TB grading: >20 (>12) Mucina: abs Necrosis: abs MSI: MSS Mutations: BRAF Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(met) MLH1(no met) NEUROG1(met) RUNX3(met) SOCS1(no met)
CP-75 Nationality: Spa Status: normal Age: 77 Grouped Age: 74 - 77 Type: Serrated Adenocarcinoma Localization: distal General loc.: sigmoid TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-76 Nationality: Spa Status: tumoral Age: 77 Grouped Age: 74 - 77 Type: Serrated Adenocarcinoma Localization: distal General loc.: sigmoid TNM: T4N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: <10 (0-5) Mucina: 50-75% Necrosis: abs MSI: MSI Mutations: BRAF Methilation: CACNA1G(met) CDKN2A(met) CRABP1(met) IGF2(met) MLH1(met) NEUROG1(met) RUNX3(met) SOCS1(no met)
CP-77 Nationality: Spa Status: tumoral Age: 75 Grouped Age: 74 - 77 Type: Conventional Carcinoma Localization: proximal General loc.: cecum TNM: TisN0M0 Grading: LG Invasion: false Perforation: false Growth: NP Budding: NO TB grading: abs Mucina: abs Necrosis: abs MSI: MSS Mutations: Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(parcial met) IGF2(parcial met) MLH1(no met) NEUROG1(parcial met) RUNX3(parcial met) SOCS1(no met)
CP-78 Nationality: Spa Status: normal Age: 74 Grouped Age: 74 - 77 Type: Conventional Carcinoma Localization: proximal General loc.: cecum TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-79 Nationality: Spa Status: tumoral Age: 74 Grouped Age: 74 - 77 Type: Conventional Carcinoma Localization: proximal General loc.: cecum TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: inf Budding: Low TB grading: <10 (0-5) Mucina: abs Necrosis: intrag MSI: MSS Mutations: Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(no met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met) View tissue
CP-80 Nationality: Spa Status: normal Age: 73 Grouped Age: 66 - 73 Type: Conventional Carcinoma Localization: proximal General loc.: cecum TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-81 Nationality: Spa Status: tumoral Age: 73 Grouped Age: 66 - 73 Type: Conventional Carcinoma Localization: proximal General loc.: cecum TNM: T3N0M0 Grading: Invasion: false Perforation: false Growth: exp Budding: Low TB grading: abs Mucina: < 50% Necrosis: abs MSI: MSS Mutations: Methilation: CACNA1G(no met) CDKN2A(parcial met) CRABP1(parcial met) IGF2(met) MLH1(no met) NEUROG1(met) RUNX3(no met) SOCS1(no met) View tissue
CP-82 Nationality: Spa Status: tumoral Age: 80 Grouped Age: 78+ Type: Serrated Adenocarcinoma Localization: rectum General loc.: rectum TNM: T3N2M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: abs Mucina: > 75% Necrosis: abs MSI: MSS Mutations: Methilation: CACNA1G(no met) CDKN2A(parcial met) CRABP1(parcial met) IGF2(met) MLH1(parcial met) NEUROG1(met) RUNX3(no met) SOCS1(no met) View tissue
CP-83 Nationality: Spa Status: normal Age: 75 Grouped Age: 74 - 77 Type: Conventional Carcinoma Localization: General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: abs Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-84 Nationality: Spa Status: normal Age: 88 Grouped Age: 78+ Type: Serrated Adenocarcinoma Localization: proximal General loc.: cecum TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-85 Nationality: Spa Status: tumoral Age: 88 Grouped Age: 78+ Type: Serrated Adenocarcinoma Localization: proximal General loc.: cecum TNM: T2N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: abs Mucina: > 75% Necrosis: abs MSI: MSS Mutations: KRAS Methilation: CACNA1G(met) CDKN2A(parcial met) CRABP1(no met) IGF2(met) MLH1(no met) NEUROG1(met) RUNX3(met) SOCS1(no met) View tissue
CP-86 Nationality: Spa Status: normal Age: 77 Grouped Age: 74 - 77 Type: Serrated Adenocarcinoma Localization: proximal General loc.: ascending TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-87 Nationality: Spa Status: tumoral Age: 77 Grouped Age: 74 - 77 Type: Serrated Adenocarcinoma Localization: proximal General loc.: ascending TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: High TB grading: 10-19 (>12) Mucina: 50-75% Necrosis: abs MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(no met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met) View tissue
CP-88 Nationality: Spa Status: tumoral Age: 63 Grouped Age: <= 65 Type: Serrated Adenocarcinoma Localization: proximal General loc.: TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: <10 (0-5) Mucina: 50-75% Necrosis: abs MSI: MSI Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(no met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met) View tissue
CP-89 Nationality: Spa Status: tumoral Age: 60 Grouped Age: <= 65 Type: Serrated Adenocarcinoma Localization: distal General loc.: TNM: T3N1M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: <10 (0-5) Mucina: abs Necrosis: abs MSI: MSS Mutations: Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(no met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met) View tissue
CP-90 Nationality: Spa Status: tumoral Age: 81 Grouped Age: 78+ Type: Serrated Adenocarcinoma Localization: proximal General loc.: TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: inf Budding: High TB grading: 10-19 (>12) Mucina: < 50% Necrosis: intrag MSI: MSS Mutations: Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(no met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met)
CP-91 Nationality: Spa Status: tumoral Age: 78 Grouped Age: 78+ Type: Serrated Adenocarcinoma Localization: proximal General loc.: TNM: T2N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: abs Mucina: > 75% Necrosis: abs MSI: MSS Mutations: Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(no met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met)
CP-92 Nationality: Spa Status: tumoral Age: 69 Grouped Age: 66 - 73 Type: Microsatellite Instable Localization: proximal General loc.: TNM: T4N2M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: abs Mucina: 50-75% Necrosis: diff MSI: MSI Mutations: Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(met) MLH1(met) NEUROG1(no met) RUNX3(no met) SOCS1(no met) View tissue
CP-93 Nationality: Spa Status: tumoral Age: 83 Grouped Age: 78+ Type: Microsatellite Instable Localization: distal General loc.: TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: abs Mucina: < 50% Necrosis: abs MSI: MSI Mutations: BRAF Methilation: CACNA1G(met) CDKN2A(met) CRABP1(met) IGF2(met) MLH1(met) NEUROG1(met) RUNX3(met) SOCS1(parcial met)
CP-94 Nationality: Spa Status: tumoral Age: 80 Grouped Age: 78+ Type: Serrated Adenocarcinoma Localization: proximal General loc.: TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: inf Budding: Low TB grading: <10 (0-5) Mucina: < 50% Necrosis: intrag MSI: Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(parcial met) IGF2(met) MLH1(no met) NEUROG1(parcial met) RUNX3(no met) SOCS1(no met)
CP-95 Nationality: Spa Status: tumoral Age: 70 Grouped Age: 66 - 73 Type: Serrated Adenocarcinoma Localization: proximal General loc.: TNM: TisN0M0 Grading: LG Invasion: false Perforation: false Growth: NP Budding: no TB grading: abs Mucina: abs Necrosis: abs MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(parcial met) MLH1(no met) NEUROG1(parcial met) RUNX3(no met) SOCS1(no met) View tissue
CP-96 Nationality: Spa Status: tumoral Age: 69 Grouped Age: 66 - 73 Type: Serrated Adenocarcinoma Localization: distal General loc.: TNM: T3N2M1 Grading: HG Invasion: false Perforation: false Growth: inf Budding: High TB grading: <10 (0-5) Mucina: < 50% Necrosis: intrag MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(parcial met) IGF2(met) MLH1(no met) NEUROG1(met) RUNX3(met) SOCS1(parcial met) View tissue
CP-97 Nationality: Spa Status: tumoral Age: 75 Grouped Age: 74 - 77 Type: Serrated Adenocarcinoma Localization: proximal General loc.: TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: <10 (0-5) Mucina: abs Necrosis: abs MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(parcial met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met)
CP-98 Nationality: Spa Status: tumoral Age: 69 Grouped Age: 66 - 73 Type: Serrated Adenocarcinoma Localization: distal General loc.: TNM: T4N2M0 Grading: HG Invasion: false Perforation: false Growth: inf Budding: High TB grading: 10-19 (>12) Mucina: abs Necrosis: intrag MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(parcial met) MLH1(no met) NEUROG1(parcial met) RUNX3(no met) SOCS1(no met)
CP-99 Nationality: Spa Status: tumoral Age: 62 Grouped Age: <= 65 Type: Conventional Carcinoma Localization: rectum General loc.: TNM: T2N0M0 Grading: LG Invasion: false Perforation: false Growth: inf Budding: Low TB grading: abs Mucina: abs Necrosis: intrag MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(no met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met) View tissue
CP-100 Nationality: Spa Status: tumoral Age: 87 Grouped Age: 78+ Type: Serrated Adenocarcinoma Localization: proximal General loc.: TNM: T4N2M1 Grading: LG Invasion: false Perforation: false Growth: inf Budding: Low TB grading: <10 (0-5) Mucina: abs Necrosis: abs MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(parcial met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met)
CP-101 Nationality: Spa Status: tumoral Age: 77 Grouped Age: 74 - 77 Type: Serrated Adenocarcinoma Localization: distal General loc.: TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: <10 (0-5) Mucina: abs Necrosis: abs MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(met) MLH1(no met) NEUROG1(parcial met) RUNX3(no met) SOCS1(no met)
CP-102 Nationality: Spa Status: tumoral Age: 65 Grouped Age: <= 65 Type: Microsatellite Instable Localization: distal General loc.: TNM: T4N1M0 Grading: HG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: abs Mucina: abs Necrosis: abs MSI: MSS Mutations: Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(no met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met)
CP-103 Nationality: Spa Status: tumoral Age: 88 Grouped Age: 78+ Type: Microsatellite Instable Localization: proximal General loc.: TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: abs Mucina: abs Necrosis: abs MSI: MSI Mutations: BRAF Methilation: CACNA1G(met) CDKN2A(met) CRABP1(met) IGF2(met) MLH1(met) NEUROG1(met) RUNX3(met) SOCS1(no met)
CP-104 Nationality: Spa Status: tumoral Age: 60 Grouped Age: <= 65 Type: Conventional Carcinoma Localization: distal General loc.: TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: abs Mucina: > 75% Necrosis: intrag MSI: Mutations: BRAF Methilation: CACNA1G(met) CDKN2A(met) CRABP1(met) IGF2(met) MLH1(met) NEUROG1(met) RUNX3(met) SOCS1(parcial met) View tissue
CP-105 Nationality: Spa Status: tumoral Age: 76 Grouped Age: 74 - 77 Type: Conventional Carcinoma Localization: proximal General loc.: TNM: T3N2M0 Grading: LG Invasion: false Perforation: false Growth: inf Budding: Low TB grading: <10 (0-5) Mucina: abs Necrosis: intrag MSI: MSS Mutations: KRAS Methilation: CACNA1G(met) CDKN2A(no met) CRABP1(no met) IGF2(met) MLH1(no met) NEUROG1(met) RUNX3(met) SOCS1(no met)
CP-106 Nationality: Spa Status: tumoral Age: 51 Grouped Age: <= 65 Type: Conventional Carcinoma Localization: distal General loc.: TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: inf Budding: Low TB grading: <10 (0-5) Mucina: abs Necrosis: intrag MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(met) MLH1(no met) NEUROG1(parcial met) RUNX3(met) SOCS1(no met)
CP-107 Nationality: Spa Status: tumoral Age: 81 Grouped Age: 78+ Type: Serrated Adenocarcinoma Localization: distal General loc.: TNM: T3N1M0 Grading: LG Invasion: false Perforation: false Growth: inf Budding: Low TB grading: <10 (0-5) Mucina: abs Necrosis: abs MSI: MSS Mutations: Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(parcial met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met)
CP-108 Nationality: Spa Status: tumoral Age: 64 Grouped Age: <= 65 Type: Serrated Adenocarcinoma Localization: distal General loc.: TNM: T2N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: <10 (0-5) Mucina: < 50% Necrosis: abs MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(no met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met)
CP-109 Nationality: Spa Status: normal Age: 68 Grouped Age: 66 - 73 Type: Serrated Adenocarcinoma Localization: proximal General loc.: TNM: T3N1M1 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: <10 (0-5) Mucina: abs Necrosis: intrag MSI: NOS Mutations: Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(no met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met)
CP-110 Nationality: Spa Status: tumoral Age: 68 Grouped Age: 66 - 73 Type: Serrated Adenocarcinoma Localization: rectum General loc.: TNM: T2N2M0 Grading: HG Invasion: false Perforation: false Growth: inf Budding: Low TB grading: <10 (0-5) Mucina: abs Necrosis: abs MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(parcial met) CRABP1(parcial met) IGF2(met) MLH1(no met) NEUROG1(met) RUNX3(no met) SOCS1(no met) View tissue
CP-111 Nationality: Spa Status: tumoral Age: 68 Grouped Age: 66 - 73 Type: Serrated Adenocarcinoma Localization: rectum General loc.: TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: inf Budding: Low TB grading: <10 (0-5) Mucina: < 50% Necrosis: intrag MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(no met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met)
CP-112 Nationality: Spa Status: tumoral Age: 67 Grouped Age: 66 - 73 Type: Conventional Carcinoma Localization: distal General loc.: TNM: T4N2M1 Grading: HG Invasion: false Perforation: false Growth: inf Budding: High TB grading: >20 (>12) Mucina: > 75% Necrosis: intrag MSI: MSS Mutations: Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(no met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met) View tissue
CP-113 Nationality: Spa Status: tumoral Age: 46 Grouped Age: <= 65 Type: Conventional Carcinoma Localization: rectum General loc.: TNM: T3N1MX Grading: LG Invasion: false Perforation: false Growth: inf Budding: High TB grading: 10-19 (>12) Mucina: abs Necrosis: intrag MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(parcial met) MLH1(no met) NEUROG1(parcial met) RUNX3(no met) SOCS1(no met)
CP-114 Nationality: Spa Status: tumoral Age: 75 Grouped Age: 74 - 77 Type: Conventional Carcinoma Localization: distal General loc.: TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: abs Mucina: > 75% Necrosis: abs MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(parcial met) MLH1(no met) NEUROG1(met) RUNX3(no met) SOCS1(no met)
CP-115 Nationality: Spa Status: tumoral Age: 84 Grouped Age: 78+ Type: Conventional Carcinoma Localization: distal General loc.: TNM: T4N1M0 Grading: LG Invasion: false Perforation: false Growth: inf Budding: Low TB grading: <10 (0-5) Mucina: abs Necrosis: intrag MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(parcial met) MLH1(parcial met) NEUROG1(parcial met) RUNX3(no met) SOCS1(no met)
CP-116 Nationality: Spa Status: tumoral Age: 85 Grouped Age: 78+ Type: Serrated Adenocarcinoma Localization: proximal General loc.: TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: inf Budding: Low TB grading: <10 (0-5) Mucina: < 50% Necrosis: intrag MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(parcial met) MLH1(no met) NEUROG1(parcial met) RUNX3(no met) SOCS1(no met)
CP-117 Nationality: Spa Status: tumoral Age: 79 Grouped Age: 78+ Type: Serrated Adenocarcinoma Localization: distal General loc.: TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: High TB grading: 10-19 (>12) Mucina: abs Necrosis: intrag MSI: MSS Mutations: Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(parcial met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met)
CP-118 Nationality: Spa Status: tumoral Age: 64 Grouped Age: <= 65 Type: Serrated Adenocarcinoma Localization: distal General loc.: TNM: T3N1M1 Grading: LG Invasion: false Perforation: false Growth: inf Budding: Low TB grading: <10 (0-5) Mucina: < 50% Necrosis: abs MSI: MSS Mutations: BRAF KRAS Methilation: CACNA1G(met) CDKN2A(parcial met) CRABP1(met) IGF2(met) MLH1(met) NEUROG1(met) RUNX3(met) SOCS1(no met) View tissue
CP-119 Nationality: Spa Status: tumoral Age: 56 Grouped Age: <= 65 Type: Conventional Carcinoma Localization: proximal General loc.: TNM: TisN0M0 Grading: LG Invasion: false Perforation: false Growth: NP Budding: NO TB grading: abs Mucina: abs Necrosis: abs MSI: MSS Mutations: KRAS Methilation: CACNA1G(parcial met) CDKN2A(no met) CRABP1(parcial met) IGF2(met) MLH1(no met) NEUROG1(met) RUNX3(met) SOCS1(no met)
CP-120 Nationality: Spa Status: tumoral Age: 67 Grouped Age: 66 - 73 Type: Conventional Carcinoma Localization: proximal General loc.: TNM: T3N1M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: <10 (0-5) Mucina: abs Necrosis: intrag MSI: MSS Mutations: Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(no met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met)
CP-121 Nationality: Spa Status: tumoral Age: 87 Grouped Age: 78+ Type: Conventional Carcinoma Localization: proximal General loc.: TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: <10 (0-5) Mucina: < 50% Necrosis: confl MSI: MSS Mutations: KRAS Methilation: CACNA1G(parcial met) CDKN2A(parcial met) CRABP1(parcial met) IGF2(met) MLH1(no met) NEUROG1(met) RUNX3(parcial met) SOCS1(no met)
CP-122 Nationality: Spa Status: tumoral Age: 51 Grouped Age: <= 65 Type: Microsatellite Instable Localization: rectum General loc.: TNM: T3N2M0 Grading: LG Invasion: false Perforation: false Growth: inf Budding: Low TB grading: abs Mucina: abs Necrosis: intrag MSI: MSI Mutations: Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(no met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met)
CP-123 Nationality: Spa Status: tumoral Age: 78 Grouped Age: 78+ Type: Serrated Adenocarcinoma Localization: distal General loc.: TNM: T2N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: <10 (0-5) Mucina: > 75% Necrosis: intrag MSI: Mutations: Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(parcial met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met) View tissue
CP-124 Nationality: Fin Status: normal Age: 88 Grouped Age: 78+ Type: Serrated Adenocarcinoma Localization: proximal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-125 Nationality: Fin Status: normal Age: 46 Grouped Age: <= 65 Type: Serrated Adenocarcinoma Localization: proximal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-126 Nationality: Fin Status: normal Age: 60 Grouped Age: <= 65 Type: Conventional Carcinoma Localization: General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-127 Nationality: Fin Status: tumoral Age: 60 Grouped Age: <= 65 Type: Serrated Adenocarcinoma Localization: proximal General loc.: TNM: T3N2M0 Grading: HG Invasion: false Perforation: false Growth: inf Budding: High TB grading: >20 (>12) Mucina: no Necrosis: confl MSI: Mutations: BRAF Methilation: CACNA1G(parcial met) CDKN2A(parcial met) CRABP1(met) IGF2(met) MLH1(parcial met) NEUROG1(met) RUNX3(met) SOCS1(no met)
CP-128 Nationality: Fin Status: tumoral Age: 88 Grouped Age: 78+ Type: Serrated Adenocarcinoma Localization: proximal General loc.: TNM: T3N0M0 Grading: HG Invasion: false Perforation: false Growth: inf Budding: Low TB grading: <10 (0-5) Mucina: <50% (<10%) Necrosis: intrag MSI: MSI Mutations: BRAF Methilation: CACNA1G(met) CDKN2A(parcial met) CRABP1(met) IGF2(met) MLH1(met) NEUROG1(met) RUNX3(met) SOCS1(no met)
CP-129 Nationality: Fin Status: tumoral Age: 86 Grouped Age: 78+ Type: Serrated Adenocarcinoma Localization: proximal General loc.: TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: inf Budding: Low TB grading: <10 (0-5) Mucina: 50-75% Necrosis: abs MSI: MSS Mutations: BRAF Methilation: CACNA1G(met) CDKN2A(met) CRABP1(met) IGF2(met) MLH1(met) NEUROG1(met) RUNX3(met) SOCS1(parcial met)
CP-130 Nationality: Fin Status: tumoral Age: 72 Grouped Age: 66 - 73 Type: Serrated Adenocarcinoma Localization: rectum General loc.: TNM: T4N2M0 Grading: HG Invasion: false Perforation: false Growth: inf Budding: Low TB grading: <10 (6-11) Mucina: abs Necrosis: confl MSI: MSS Mutations: KRAS Methilation: CACNA1G(parcial met) CDKN2A(parcial met) CRABP1(parcial met) IGF2(no met) MLH1(no met) NEUROG1(met) RUNX3(parcial met) SOCS1(no met)
CP-131 Nationality: Fin Status: tumoral Age: 84 Grouped Age: 78+ Type: Serrated Adenocarcinoma Localization: proximal General loc.: TNM: T2N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: <10 (0-5) Mucina: <50% Necrosis: abs MSI: MSI Mutations: BRAF Methilation: CACNA1G(met) CDKN2A(parcial met) CRABP1(met) IGF2(met) MLH1(met) NEUROG1(met) RUNX3(met) SOCS1(no met)
CP-132 Nationality: Fin Status: tumoral Age: 68 Grouped Age: 66 - 73 Type: Serrated Adenocarcinoma Localization: proximal General loc.: TNM: T4N2M1 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: <10 (0-5) Mucina: <50% Necrosis: abs MSI: MSS Mutations: BRAF Methilation: CACNA1G(no met) CDKN2A(parcial met) CRABP1(parcial met) IGF2(met) MLH1(no met) NEUROG1(met) RUNX3(parcial met) SOCS1(no met)
CP-133 Nationality: Fin Status: tumoral Age: 60 Grouped Age: <= 65 Type: Conventional Carcinoma Localization: proximal General loc.: TNM: T3N2M0 Grading: LG Invasion: false Perforation: false Growth: inf Budding: High TB grading: 10-19 (>12) Mucina: <50% Necrosis: confl MSI: MSS Mutations: KRAS Methilation: CACNA1G(met) CDKN2A(no met) CRABP1(met) IGF2(met) MLH1(parcial met) NEUROG1(met) RUNX3(met) SOCS1(no met)
CP-134 Nationality: Fin Status: tumoral Age: 76 Grouped Age: 74 - 77 Type: Serrated Adenocarcinoma Localization: proximal General loc.: TNM: T3N2M0 Grading: HG Invasion: false Perforation: false Growth: inf Budding: Low TB grading: <10 (0-5) Mucina: >75% Necrosis: abs MSI: MSS Mutations: BRAF Methilation: CACNA1G(met) CDKN2A(no met) CRABP1(met) IGF2(met) MLH1(met) NEUROG1(met) RUNX3(met) SOCS1(parcial met)
CP-135 Nationality: Fin Status: tumoral Age: 70 Grouped Age: 66 - 73 Type: Serrated Adenocarcinoma Localization: proximal General loc.: TNM: T4N0M0 Grading: LG Invasion: false Perforation: false Growth: inf Budding: High TB grading: 10-19 (>12) Mucina: 50-75% Necrosis: abs MSI: MSI Mutations: BRAF Methilation: CACNA1G(met) CDKN2A(parcial met) CRABP1(met) IGF2(met) MLH1(met) NEUROG1(met) RUNX3(parcial met) SOCS1(no met)
CP-136 Nationality: Fin Status: tumoral Age: 60 Grouped Age: <= 65 Type: Conventional Carcinoma Localization: proximal General loc.: TNM: T3N1M1 Grading: LG Invasion: false Perforation: false Growth: inf Budding: Low TB grading: <10 (6-11) Mucina: abs Necrosis: confl MSI: MSS Mutations: Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(parcial met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met)
CP-137 Nationality: Fin Status: tumoral Age: 68 Grouped Age: 66 - 73 Type: Conventional Carcinoma Localization: rectum General loc.: TNM: T3N2M1 Grading: HG Invasion: false Perforation: false Growth: inf Budding: Low TB grading: <10 (0-5) Mucina: abs Necrosis: intrag MSI: MSS Mutations: BRAF Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(parcial met) MLH1(no met) NEUROG1(met) RUNX3(met) SOCS1(no met)
CP-138 Nationality: Fin Status: tumoral Age: 60 Grouped Age: <= 65 Type: Serrated Adenocarcinoma Localization: proximal General loc.: TNM: T3N2M1 Grading: LG Invasion: false Perforation: false Growth: inf Budding: High TB grading: 10-19 (6-11) Mucina: abs Necrosis: intrag MSI: MSS Mutations: Methilation: CACNA1G(no met) CDKN2A(parcial met) CRABP1(parcial met) IGF2(met) MLH1(no met) NEUROG1(parcial met) RUNX3(no met) SOCS1(no met)
CP-139 Nationality: Fin Status: tumoral Age: 72 Grouped Age: 66 - 73 Type: Conventional Carcinoma Localization: proximal General loc.: TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: <10 (0-5) Mucina: abs Necrosis: intrag MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(parcial met) MLH1(no met) NEUROG1(parcial met) RUNX3(no met) SOCS1(no met)
CP-140 Nationality: Fin Status: tumoral Age: 76 Grouped Age: 74 - 77 Type: Serrated Adenocarcinoma Localization: proximal General loc.: TNM: T3N1M0 Grading: LG Invasion: false Perforation: false Growth: inf Budding: Low TB grading: <10 (6-11) Mucina: >75% Necrosis: abs MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(met) MLH1(parcial met) NEUROG1(no met) RUNX3(no met) SOCS1(no met)
CP-141 Nationality: Fin Status: tumoral Age: 63 Grouped Age: <= 65 Type: Conventional Carcinoma Localization: rectum General loc.: TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: inf Budding: High TB grading: 10-19 (>12) Mucina: abs Necrosis: abs MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(met) MLH1(no met) NEUROG1(parcial met) RUNX3(no met) SOCS1(no met)
CP-142 Nationality: Fin Status: tumoral Age: 75 Grouped Age: 74 - 77 Type: Serrated Adenocarcinoma Localization: distal General loc.: TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: <10 (0-5) Mucina: <50% (<10%) Necrosis: intrag MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(parcial met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met)
CP-143 Nationality: Fin Status: tumoral Age: 73 Grouped Age: 66 - 73 Type: Conventional Carcinoma Localization: rectum General loc.: TNM: T3N1M0 Grading: HG Invasion: false Perforation: false Growth: inf Budding: High TB grading: >20 (>12) Mucina: abs Necrosis: confl MSI: MSS Mutations: Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(met) MLH1(no met) NEUROG1(parcial met) RUNX3(no met) SOCS1(no met)
CP-144 Nationality: Fin Status: tumoral Age: 78 Grouped Age: 78+ Type: Serrated Adenocarcinoma Localization: rectum General loc.: TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: inf Budding: Low TB grading: 10-19 (6-11) Mucina: <50% Necrosis: diffuse MSI: MSS Mutations: Methilation: CACNA1G(parcial met) CDKN2A(no met) CRABP1(no met) IGF2(met) MLH1(no met) NEUROG1(met) RUNX3(no met) SOCS1(no met)
CP-145 Nationality: Fin Status: tumoral Age: 46 Grouped Age: <= 65 Type: Serrated Adenocarcinoma Localization: proximal General loc.: TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: <10 (0-5) Mucina: <50% Necrosis: abs MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(met) MLH1(no met) NEUROG1(parcial met) RUNX3(no met) SOCS1(no met)
CP-146 Nationality: Fin Status: tumoral Age: 60 Grouped Age: <= 65 Type: Serrated Adenocarcinoma Localization: rectum General loc.: TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: <10 (0-5) Mucina: <50% Necrosis: intrag MSI: MSS Mutations: Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(parcial met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met)
CP-147 Nationality: Fin Status: tumoral Age: 75 Grouped Age: 74 - 77 Type: Conventional Carcinoma Localization: distal General loc.: TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: inf Budding: High TB grading: 10-19 (>12) Mucina: abs Necrosis: abs MSI: MSS Mutations: Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(met) IGF2(met) MLH1(no met) NEUROG1(parcial met) RUNX3(no met) SOCS1(no met)
CP-148 Nationality: Fin Status: tumoral Age: 74 Grouped Age: 74 - 77 Type: Serrated Adenocarcinoma Localization: rectum General loc.: TNM: T3N2M0 Grading: HG Invasion: false Perforation: false Growth: inf Budding: High TB grading: >20 (>12) Mucina: <50% Necrosis: abs MSI: MSS Mutations: Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(no met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met)
CP-149 Nationality: Fin Status: tumoral Age: 74 Grouped Age: 74 - 77 Type: Serrated Adenocarcinoma Localization: rectum General loc.: TNM: T3N1M0 Grading: LG Invasion: false Perforation: false Growth: inf Budding: Low TB grading: <10 (0-5) Mucina: abs Necrosis: abs MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(parcial met) CRABP1(no met) IGF2(met) MLH1(no met) NEUROG1(parcial met) RUNX3(no met) SOCS1(no met)
CP-150 Nationality: Fin Status: normal Age: 73 Grouped Age: 66 - 73 Type: Conventional Carcinoma Localization: General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-151 Nationality: Fin Status: normal Age: 60 Grouped Age: <= 65 Type: Conventional Carcinoma Localization: General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-152 Nationality: Fin Status: normal Age: 75 Grouped Age: 74 - 77 Type: Serrated Adenocarcinoma Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-153 Nationality: Fin Status: tumoral Age: 52 Grouped Age: <= 65 Type: Serrated Adenocarcinoma Localization: proximal General loc.: TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: inf Budding: Low TB grading: <10 (6-11) Mucina: abs Necrosis: intrag MSI: MSS Mutations: Methilation: CACNA1G(no met) CDKN2A(parcial met) CRABP1(parcial met) IGF2(met) MLH1(no met) NEUROG1(parcial met) RUNX3(no met) SOCS1(no met)
CP-154 Nationality: Fin Status: tumoral Age: 76 Grouped Age: 74 - 77 Type: Serrated Adenocarcinoma Localization: rectum General loc.: TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: <10 (0-5) Mucina: abs Necrosis: abs MSI: MSS Mutations: Methilation: CACNA1G(no met) CDKN2A(parcial met) CRABP1(parcial met) IGF2(parcial met) MLH1(no met) NEUROG1(parcial met) RUNX3(no met) SOCS1(no met)
CP-155 Nationality: Fin Status: tumoral Age: 71 Grouped Age: 66 - 73 Type: Conventional Carcinoma Localization: rectum General loc.: TNM: T4N1M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: <10 (0-5) Mucina: abs Necrosis: diff MSI: MSS Mutations: Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(parcial met) MLH1(parcial met) NEUROG1(no met) RUNX3(no met) SOCS1(no met)
CP-156 Nationality: Fin Status: tumoral Age: 71 Grouped Age: 66 - 73 Type: Conventional Carcinoma Localization: rectum General loc.: TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: exp Budding: Low TB grading: <10 (6-11) Mucina: abs Necrosis: confl MSI: MSS Mutations: KRAS Methilation: CACNA1G(no met) CDKN2A(no met) CRABP1(no met) IGF2(no met) MLH1(no met) NEUROG1(no met) RUNX3(no met) SOCS1(no met)
CP-157 Nationality: Fin Status: normal Age: 75 Grouped Age: 74 - 77 Type: Conventional Carcinoma Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-158 Nationality: Fin Status: normal Age: 78 Grouped Age: 78+ Type: Serrated Adenocarcinoma Localization: rectum General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-159 Nationality: Spa Status: tumoral Age: 42 Grouped Age: <= 65 Type: Mucinous Adenoma Localization: distal General loc.: sigmoid TNM: T3N1MX Grading: Invasion: Perforation: Growth: Budding: TB grading: Mucina: Necrosis: MSI: MSS Mutations: Methilation:
CP-160 Nationality: Spa Status: tumoral Age: 64 Grouped Age: <= 65 Type: Serrated Adenocarcinoma Localization: rectum General loc.: rectum TNM: T3N0M0 Grading: LG Invasion: false Perforation: false Growth: Budding: High TB grading: >20 Mucina: > 75% Necrosis: abs MSI: MSS Mutations: Methilation:
CP-161 Nationality: Spa Status: tumoral Age: 69 Grouped Age: 66 - 73 Type: Conventional Carcinoma Localization: rectum General loc.: rectum TNM: T3N1MX Grading: Invasion: Perforation: Growth: Budding: TB grading: Mucina: Necrosis: MSI: MSS Mutations: Methilation:
CP-162 Nationality: Spa Status: tumoral Age: 76 Grouped Age: 74 - 77 Type: Serrated Adenocarcinoma Localization: distal General loc.: sigmoid TNM: T1N0M0 Grading: LG Invasion: false Perforation: false Growth: expansivo Budding: Low TB grading: 0 Mucina: > 75% Necrosis: abs MSI: Mutations: Methilation:
CP-163 Nationality: Spa Status: tumoral Age: 63 Grouped Age: <= 65 Type: Serrated Adenocarcinoma Localization: rectum General loc.: sigmoid TNM: T3N2MX Grading: LG Invasion: false Perforation: false Growth: Budding: Low TB grading: <10 Mucina: Necrosis: abs MSI: MSS Mutations: Methilation:
CP-164 Nationality: Spa Status: tumoral Age: 69 Grouped Age: 66 - 73 Type: Serrated Adenocarcinoma Localization: proximal General loc.: cecum TNM: T4N2MX Grading: Invasion: false Perforation: Growth: Budding: Low TB grading: <10 Mucina: < 50% Necrosis: MSI: MSI-H Mutations: Methilation:
CP-166 Nationality: Spa Status: tumoral Age: 59 Grouped Age: <= 65 Type: Mucinous Adenoma Localization: rectum General loc.: rectum TNM: T3N0M0 Grading: Invasion: Perforation: Growth: Budding: TB grading: Mucina: Necrosis: MSI: Mutations: Methilation:
CP-167 Nationality: Spa Status: tumoral Age: 61 Grouped Age: <= 65 Type: Conventional Carcinoma Localization: rectum General loc.: rectum TNM: T3N2MX Grading: Invasion: false Perforation: false Growth: Budding: TB grading: Mucina: Necrosis: confl MSI: Mutations: Methilation:
CP-168 Nationality: Spa Status: tumoral Age: 76 Grouped Age: 74 - 77 Type: Conventional Carcinoma Localization: distal General loc.: TNM: T3N1MX Grading: Invasion: Perforation: Growth: Budding: TB grading: Mucina: Necrosis: MSI: MSS Mutations: Methilation:
CP-169 Nationality: Spa Status: polyp Age: 71 Grouped Age: 66 - 73 Type: NOS Localization: proximal General loc.: ascending TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-170 Nationality: Spa Status: normal Age: 64 Grouped Age: <= 65 Type: NOS Localization: General loc.: rectum TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-171 Nationality: Spa Status: polyp Age: 76 Grouped Age: 74 - 77 Type: NOS Localization: distal General loc.: sigmoid TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-172 Nationality: Spa Status: normal Age: 65 Grouped Age: <= 65 Type: NOS Localization: proximal General loc.: cecum TNM: NOSNOSNOS Grading: NOS Invasion: false Perforation: false Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-194 Nationality: Spa Status: polyp Age: 66 Grouped Age: 66 - 73 Type: Tubular Adenoma Localization: proximal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-195 Nationality: Spa Status: polyp Age: 62 Grouped Age: <= 65 Type: Tubular Adenoma Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-196 Nationality: Spa Status: polyp Age: 78 Grouped Age: 78+ Type: Traditional serrated adenoma+Tubular villious adenoma Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-197 Nationality: Spa Status: polyp Age: 78 Grouped Age: 78+ Type: Tubular villious adenoma+Pathological tumor in situ Localization: proximal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-198 Nationality: Spa Status: polyp Age: 72 Grouped Age: 66 - 73 Type: Traditional serrated adenoma+Tubular villious adenoma+High grade dysplasia Localization: proximal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-199 Nationality: Spa Status: normal Age: 71 Grouped Age: 66 - 73 Type: Normal Mucose Localization: proximal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-200 Nationality: Spa Status: normal Age: 78 Grouped Age: 78+ Type: Normal Mucose Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-201 Nationality: Spa Status: polyp Age: 78 Grouped Age: 78+ Type: Tubular villious adenoma+Pathological tumor in situ Localization: proximal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-202 Nationality: Spa Status: normal Age: 71 Grouped Age: 66 - 73 Type: Normal Mucose Localization: proximal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-203 Nationality: Spa Status: normal Age: 42 Grouped Age: <= 65 Type: Normal Mucose Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-204 Nationality: Spa Status: normal Age: 71 Grouped Age: 66 - 73 Type: Normal Mucose Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-205 Nationality: Spa Status: normal Age: 42 Grouped Age: <= 65 Type: Normal Mucose Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-206 Nationality: Spa Status: normal Age: 63 Grouped Age: <= 65 Type: Normal Mucose Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-207 Nationality: Spa Status: normal Age: 63 Grouped Age: <= 65 Type: Normal Mucose Localization: proximal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-208 Nationality: Spa Status: normal Age: 45 Grouped Age: <= 65 Type: Normal Mucose Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-209 Nationality: Spa Status: polyp Age: 68 Grouped Age: 66 - 73 Type: Tubular adenoma+Low grade dysplasia Localization: proximal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-210 Nationality: Spa Status: normal Age: 45 Grouped Age: <= 65 Type: Normal Mucose Localization: proximal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-211 Nationality: Spa Status: polyp Age: 87 Grouped Age: 78+ Type: Villious Adenoma Localization: proximal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-212 Nationality: Spa Status: polyp Age: 70 Grouped Age: 66 - 73 Type: Tubular Villious Adenoma Localization: General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-213 Nationality: Spa Status: polyp Age: 85 Grouped Age: 78+ Type: Tubular Villious Adenoma Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-214 Nationality: Spa Status: polyp Age: 81 Grouped Age: 78+ Type: Traditional serrated adenoma+Tubular villious adenoma Localization: proximal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-215 Nationality: Spa Status: polyp Age: 88 Grouped Age: 78+ Type: Sesil Serrated Adenoma Localization: proximal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-216 Nationality: Spa Status: polyp Age: 78 Grouped Age: 78+ Type: Tubular Adenoma Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-217 Nationality: Spa Status: polyp Age: 90 Grouped Age: 78+ Type: Traditional serrated adenoma+Pathological tumor in situ Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-218 Nationality: Spa Status: polyp Age: 62 Grouped Age: <= 65 Type: Traditional serrated adenoma+Pathological tumor in situ Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-219 Nationality: Spa Status: polyp Age: 70 Grouped Age: 66 - 73 Type: Tubular Adenoma Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-220 Nationality: Spa Status: polyp Age: 51 Grouped Age: <= 65 Type: Tubular Adenoma Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-221 Nationality: Spa Status: polyp Age: 68 Grouped Age: 66 - 73 Type: Tubular Adenoma Localization: proximal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-222 Nationality: Spa Status: polyp Age: 75 Grouped Age: 74 - 77 Type: Traditional serrated adenoma+Tubular villious adenoma+Pathological tumor in situ Localization: proximal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-223 Nationality: Spa Status: normal Age: 70 Grouped Age: 66 - 73 Type: Normal Mucose Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-224 Nationality: Spa Status: normal Age: 70 Grouped Age: 66 - 73 Type: Normal Mucose Localization: proximal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-225 Nationality: Spa Status: normal Age: 66 Grouped Age: 66 - 73 Type: Normal Mucose Localization: proximal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-226 Nationality: Spa Status: normal Age: 66 Grouped Age: 66 - 73 Type: Normal Mucose Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-227 Nationality: Spa Status: normal Age: 78 Grouped Age: 78+ Type: Normal Mucose Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-228 Nationality: Spa Status: normal Age: 78 Grouped Age: 78+ Type: Normal Mucose Localization: proximal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-229 Nationality: Spa Status: normal Age: 62 Grouped Age: <= 65 Type: Normal Mucose Localization: proximal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-230 Nationality: Spa Status: polyp Age: 70 Grouped Age: 66 - 73 Type: Normal Mucose Localization: proximal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-231 Nationality: Spa Status: polyp Age: 84 Grouped Age: 78+ Type: Tubular villious adenoma+Pathological tumor in situ Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-232 Nationality: Spa Status: polyp Age: 72 Grouped Age: 66 - 73 Type: Traditional serrated adenoma+Pathological tumor in situ Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-233 Nationality: Spa Status: polyp Age: 62 Grouped Age: <= 65 Type: Villious Adenoma+High grade dysplasia Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-234 Nationality: Spa Status: polyp Age: 73 Grouped Age: 66 - 73 Type: Tubular Adenoma Localization: proximal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-235 Nationality: Spa Status: normal Age: 73 Grouped Age: 66 - 73 Type: Normal Mucose Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-236 Nationality: Spa Status: normal Age: 73 Grouped Age: 66 - 73 Type: Normal Mucose Localization: proximal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-237 Nationality: Spa Status: normal Age: 81 Grouped Age: 78+ Type: Normal Mucose Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-238 Nationality: Spa Status: polyp Age: 70 Grouped Age: 66 - 73 Type: Tubular Adenoma Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-239 Nationality: Spa Status: normal Age: 81 Grouped Age: 78+ Type: Normal Mucose Localization: proximal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-240 Nationality: Spa Status: polyp Age: 81 Grouped Age: 78+ Type: Serrated adenoma+Tubular Villious Adenoma+Pathological Tumor In Situ Localization: proximal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-241 Nationality: Spa Status: normal Age: 83 Grouped Age: 78+ Type: Normal Mucose Localization: General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-242 Nationality: Spa Status: polyp Age: 83 Grouped Age: 78+ Type: Traditional serrated adenoma+Pathological tumor in situ Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-243 Nationality: Spa Status: normal Age: 62 Grouped Age: <= 65 Type: Normal Mucose Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-244 Nationality: Spa Status: normal Age: 62 Grouped Age: <= 65 Type: Normal Mucose Localization: proximal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-245 Nationality: Spa Status: polyp Age: 79 Grouped Age: 78+ Type: Tubular villious adenoma+High grade dysplasia Localization: proximal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-246 Nationality: Spa Status: polyp Age: 54 Grouped Age: <= 65 Type: Sesil serrated adenoma+Pathological Tumor In Situ Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-247 Nationality: Spa Status: polyp Age: 71 Grouped Age: 66 - 73 Type: Tubular Villious Adenoma Localization: proximal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-248 Nationality: Spa Status: polyp Age: 53 Grouped Age: <= 65 Type: Hyperplasic Polyp Localization: proximal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-249 Nationality: Spa Status: polyp Age: 51 Grouped Age: <= 65 Type: Tubular Adenoma Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-250 Nationality: Spa Status: polyp Age: 80 Grouped Age: 78+ Type: Traditional serrated adenoma+Submucosal invasion Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-251 Nationality: Spa Status: polyp Age: 88 Grouped Age: 78+ Type: Tubular Adenoma Localization: General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-252 Nationality: Spa Status: polyp Age: 59 Grouped Age: <= 65 Type: Tubular Adenoma Localization: proximal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-302 Nationality: Spa Status: polyp Age: 72 Grouped Age: 66 - 73 Type: Tubular Villious Adenoma Localization: General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-303 Nationality: Spa Status: polyp Age: 69 Grouped Age: 66 - 73 Type: Traditional Serrated Adenoma Localization: rectum General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-304 Nationality: Spa Status: polyp Age: 80 Grouped Age: 78+ Type: Villious Adenoma+Pathological tumor in situ Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-305 Nationality: Spa Status: polyp Age: 50 Grouped Age: <= 65 Type: Tubular Adenoma Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-307 Nationality: Spa Status: polyp Age: 85 Grouped Age: 78+ Type: Traditional Serrated Adenoma Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-308 Nationality: Spa Status: polyp Age: 66 Grouped Age: 66 - 73 Type: Tubular adenoma+Traditional serrated adenoma Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-309 Nationality: Spa Status: polyp Age: 56 Grouped Age: <= 65 Type: Villious Adenoma Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-310 Nationality: Spa Status: polyp Age: 60 Grouped Age: <= 65 Type: Tubular Adenoma Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-311 Nationality: Spa Status: polyp Age: 63 Grouped Age: <= 65 Type: Tubular Villious Adenoma Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-312 Nationality: Spa Status: polyp Age: 61 Grouped Age: <= 65 Type: Villious Adenoma Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-313 Nationality: Spa Status: polyp Age: 80 Grouped Age: 78+ Type: Tubular Adenoma Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-314 Nationality: Spa Status: polyp Age: 76 Grouped Age: 74 - 77 Type: Tubular Adenoma Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-315 Nationality: Spa Status: polyp Age: 76 Grouped Age: 74 - 77 Type: Tubular Villious Adenoma Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-316 Nationality: Eng Status: polyp Age: 71 Grouped Age: 66 - 73 Type: Tubular Villious Adenoma Localization: proximal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-317 Nationality: Eng Status: polyp Age: 71 Grouped Age: 66 - 73 Type: Tubular Villious Adenoma Localization: General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-318 Nationality: Spa Status: polyp Age: 52 Grouped Age: <= 65 Type: Serrated Adenocarcinoma Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-319 Nationality: Spa Status: polyp Age: 77 Grouped Age: 74 - 77 Type: Villious Adenoma Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-320 Nationality: Spa Status: polyp Age: 83 Grouped Age: 78+ Type: Tubular Villious Adenoma Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-321 Nationality: Spa Status: polyp Age: 68 Grouped Age: 66 - 73 Type: Tubular Villious Adenoma Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-322 Nationality: Spa Status: polyp Age: 77 Grouped Age: 74 - 77 Type: Villious Adenoma+Submucosal invasion Localization: General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-323 Nationality: Spa Status: polyp Age: 58 Grouped Age: <= 65 Type: Tubular Adenoma Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-324 Nationality: Spa Status: polyp Age: 62 Grouped Age: <= 65 Type: Tubular Adenoma Localization: distal General loc.: TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:
CP-325 Nationality: Spa Status: normal Age: 74 Grouped Age: 74 - 77 Type: NOS Localization: proximal General loc.: cecum TNM: NOSNOSNOS Grading: NOS Invasion: Perforation: Growth: NOS Budding: NOS TB grading: NOS Mucina: NOS Necrosis: NOS MSI: NOS Mutations: Methilation:

Analysis saved

Methylation Genes Selected

Clinical cases

CP-1

CP-2

CP-3

CP-4

CP-5

CP-6

CP-7

CP-8

CP-9

CP-10

CP-11

CP-12

CP-13

CP-14

CP-15

CP-16

CP-17

CP-18

CP-19

CP-20

CP-21

CP-22

CP-23

CP-24

CP-25

CP-26

CP-27

CP-28

CP-29

CP-30

CP-31

CP-32

CP-33

CP-34

CP-35

CP-36

CP-37

CP-38

CP-39

CP-40

CP-41

CP-42

CP-43

CP-44

CP-45

CP-46

CP-47

CP-48

CP-49

CP-50

CP-51

CP-52

CP-53

CP-54

CP-55

CP-56

CP-57

CP-58

CP-59

CP-60

CP-61

CP-62

CP-63

CP-64

CP-65

CP-66

CP-67

CP-68

CP-69

CP-70

CP-71

CP-72

CP-73

CP-74

CP-75

CP-76

CP-77